This is the authors' abstract. We don't add key points for this paper.
Successful surgical monotherapy for a patient with low-risk head and neck nonparameningeal rhabdomyosarcoma with genetic profilingTo the Editor: Rhabdomyosarcoma involving the nonparameningeal head and neck region (HNnPM RMS) is known to be a unique subgroup with a better prognosis with local aggressive nature.1,2 In this site, the frequent treatment failures include locoregional relapse/progression under the current standard therapy, which includes multiagent chemotherapy for all risk strata.2,3 However, only a few cases are deemed resectable with sufficient margins owing to the difficulty of avoiding significant functional and cosmetic sequelae.4 Thus, because of the insufficient number of cases, the clinical question of whether the intensity of adjuvant chemotherapy can be possibly reduced when this highly localized tumor is completely resected has not yet been fully addressed.A recent report shed light on the possibility of safely reducing chemotherapy intensity in patients with completely resected low-risk RMS, even in nongenitourinary sites.5 However, the extent to which the treatment intensity can be safely reduced remains unclear.With the advances in next-generation sequencing technologies, novel genetic prognostic factors, such as MyoD1 mutation and tumor mutation burden, have been reported in RMS.6,7 Because genetic factors are not yet part of the current stratification methods, their addition could enable a more sophisticated risk stratification.Here, we report a female patient with localized HNnPM RMS who survived over 6 years without recurrence.The patient underwent radical resection without chemoradiotherapy due to prolonged postoperative infection and the patient's informed choice.We retrospectively conducted whole-exome sequencing (WES), which indicated that she did not have any novel poor prognostic factors.A 17-year-old female patient presented with an indolent mass on the oral floor.The initial diagnosis was nonmalignant tumor, and unplanned resection was performed three times within 6 months for the regrowing mass.After the third surgery, the resected specimen was pathologically examined for the first time, and the result indicated that the recurrent mass was malignant.The patient was referred to our hospital and underwent follow-up surgery due to positive margins.Due to specimen insufficiency, the mass was tentatively diagnosed as lowgrade malignant myoepithelioma-like tumor.Thus, after the removal of the residual lesions, the patient was followed up on an outpatient basis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tsumura et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: